Insight Molecular Diagnostics Inc. GAAP EPS of -$0.12 beats by $0.14, revenue of $0.32M beats by $0.09M
Insight Molecular Diagnostics Inc. Common Stock · IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES · Now $6.16
+26% in 1d after detection
Post-detection moves
1h
—
1d
+26%
3d
+25%
7d
+19%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS